1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane has been researched along with carbostyril in 1 studies
Studies (1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane) | Trials (1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane) | Recent Studies (post-2010) (1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane) | Studies (carbostyril) | Trials (carbostyril) | Recent Studies (post-2010) (carbostyril) |
---|---|---|---|---|---|
36 | 1 | 9 | 12,855 | 1,323 | 5,611 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Liu, H; Ni, PZ; Ran, CZ; Xia, L | 1 |
1 other study(ies) available for 1-(2,6-dimethylphenoxy)-2-(3,4-dimethoxyphenylethylamino)propane and carbostyril
Article | Year |
---|---|
[Synthesis and anti alpha-adrenoceptor activity in vitro of 4-((4-((2-substitutedphenoxy)ethyl)-1-piperazinyl) methyl)- 1,2-dihydro-quinoline-2-one compounds].
Topics: Adrenergic alpha-Antagonists; Animals; Aorta; In Vitro Techniques; Molecular Structure; Phenethylamines; Quinolones; Rabbits; Receptors, Adrenergic, alpha; Technology, Pharmaceutical | 2002 |